Recent advances in the field of obesity treatment have generated a innovative candidate known as ALLUVI Retatrutide. This medication is a {highlyeffective GLP-1 receptor agonist, formulated to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown remarkable efficacy in clinical trials, demonstrating significant decreases in bo